TY  - RPRT
TI  - GLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and Cardiometabolic Dysfunction.
AU  - Joshua Reitz
AU  - Daniel B Rosoff
AU  - Pal Pacher
AU  - Falk W Lohoff
PY  - 2026
DO  - 10.1016/j.bpsgos.2026.100793
UR  - https://pubmed.ncbi.nlm.nih.gov/42741173/
ID  - 42741173
ER  -